• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Study on the System Detecting the residual Leukeinic Cells after the Gene-targeted Therapy forLeukemia

Research Project

Project/Area Number 14572176
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionTokyo Medical and Dental University

Principal Investigator

MARA Nobuo  Tokyo Medical and Dental University, Center for Education Research in Medicine and Dentistry, Professor, 医歯学教育システム研究センター, 教授 (00142258)

Co-Investigator(Kenkyū-buntansha) MURAKAMI Naomi  Tokyo Medical and Dental University, Department of Medicine, Assistant, 医学部附属病院, 助手 (50143582)
TONOA Shinji  Tokyo Medical and Dental University, Postgraduate School, Associate Professor, 大学院・医歯学総合研究所, 助教授 (80251510)
Project Period (FY) 2002 – 2003
KeywordsAcute Myelovlastiv Leukemia / Residnal Leukemia Cells / Gene-targeted Therapy
Research Abstract

1.Leukeinic Cell Culture.
Leukemic blast progenitors were cultured either in methylcellulose media and suspension culture before and after the leukemic patients recieved therapy. The growth of blast progenitors in methylcellulose showed their proliferative activity, while the growth in suspension supported their self-renewal capacity.
2.Detection of Chimeric Fusion Oncogenes
Some leukemic cells showed typical chimeric fusion oncogene such as PML/RARA, AML1/MTG8J and BCR/ABL. Detection of these genes showed the presence of leukemic cells even if leukemia patients were clinically considered as in remission. Firtherinore we studied the effects of Notch ligand on the grwoth of U937 leukemic cell line in the presence of GM-CSF.
3.Resuits
There was a significant correlation between the residual leukemic cells with high self-renewal capacity and/or chimeric fusion oncogene and the clinical course of the patients with acute leukemia. Those patients whose leukemic blast progenitors had high self-renewal capcity showed much poor prognosis.

  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Tohda S, Sakano S, Ohsawa M, Murakami N, nara N: "A novel cell line derived from de novo acute myeloblastic leukemia with trilineage myelodysplasia which proliferates in response to a Notch ligand, Delta-1 protein."International Journal of Oncology. 22. 1073-1079 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murata-Ohsawa M, Tohda S, Sakano S, Nara N: "The notch ligand, Delta-1, partially inhibits GM-CSF-induced differentiation and apoptosis along with reducing the cleavage of PARP in U937 cells."International Journal of Molecular Medicine. 13. 419-423 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 奈良 信雄: "BCR-ABLキメラ遺伝子定量"Medical Technology. 31. 817-818 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 奈良 信雄: "染色体分析、FISH法、SKY法"臨床病理レビュー特集号. 126. 124-130 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 奈良 信雄(訳): "ウィリアムズ血液学マニュアル"メディカル・サイエンス・インターナショナル社. 598 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tohda S, Sakano S, Ohsawa M, Murakami N, Nara N: "A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates Notch ligand Delta-1 protein."International Journal of Oncology. 22. 1073-1079 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murata-Ohsawa M, Tohda S, Sakano S, Nara N: "The notch ligand, Delta-1,partially inhibits GM-CSF-induced differentiation and apoptosis along with reducing the c1eavage pf PARP in U937 cells."International Journal of Molecular Medicine. 31. 419-423 (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi